B AND A TRADING CORPORATION is recalling 40 packages of Kushim Tablets (also known as Gushim) in 45-count containers. These products were marketed without an approved New Drug Application or Abbreviated New Drug Application, meaning they have not been evaluated by the FDA for safety or effectiveness. Laboratory analysis discovered the tablets contain cinobufagin, bufalin, and bufotenine, which are substances that can have serious effects on the heart and nervous system. These tablets featured labels in a foreign language and were distributed only in New York and New Jersey.
The product contains cinobufagin, bufalin, and bufotenine, which are potent compounds typically derived from toad venom that can cause irregular heartbeats, dangerously high blood pressure, and respiratory distress. These substances pose a significant health risk because they can lead to cardiac arrest or death if ingested.
Manufacturer refund and healthcare consultation.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.